Back to Search Start Over

Case of bullous pemphigoid refractory to corticosteroids by antiepileptic drug‐induced CYP3A4.

Authors :
Asakawa, Riko
Ogawa, Youichi
Maejima, Eri
Honobe‐Tabuchi, Akiko
Okamoto, Takashi
Mitsui, Hiroshi
Kagawa, Yoshiyuki
Shimada, Shinji
Kawamura, Tatsuyoshi
Source :
Journal of Dermatology; Feb2023, Vol. 50 Issue 2, p254-257, 4p
Publication Year :
2023

Abstract

The most common treatment option for patients with bullous pemphigoid is systemic corticosteroids. CYP3A4, a drug‐metabolizing enzyme in the liver, metabolizes synthetic steroids to a varying degree. Although there are many CYP3A4‐inducing drugs, several antiepileptic drugs, such as phenytoin and phenobarbital, strongly induce CYP3A4, thereby reducing the effects of corticosteroids. Here, we report a case of refractory bullous pemphigoid that rapidly improved after the discontinuation of phenytoin and phenobarbital. To achieve adequate pharmacological effects of corticosteroids, we must always ensure that patients who require corticosteroids for treatment are not medicated with CYP3A4‐inducing agents. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03852407
Volume :
50
Issue :
2
Database :
Complementary Index
Journal :
Journal of Dermatology
Publication Type :
Academic Journal
Accession number :
161658257
Full Text :
https://doi.org/10.1111/1346-8138.16624